Table 2.

Observed (March 2020–February 2021) vs. expected (March 2020–February 2021) pathology report volume in 11 SEER registries (*P < 0.05).

		Biopsy		Surgical		Cytology		Molecular/biomarkers		Otherb		Total
		Observed	O/E	Observed	O/E	Observed	O/E	Observed	O/E	Observed	O/E	Observed	O/E
Sex	Male	173,341	0.93*	52,346	0.89*	37,346	0.97*	6,564	1.07*	46,821	0.99	316,418	0.94*
	Female	243,046	0.89*	84,516	0.89*	40,518	0.96*	14,677	1.01	39,912	0.92*	422,669	0.90*
Age (Yrs.)	<50	62,712	0.92*	26,985	0.89*	11,935	0.92*	4,126	1.05*	17,165	0.96*	122,923	0.93*
	50–64	135,240	0.91*	48,469	0.89*	23,294	0.99	7,050	1.09*	25,024	0.95*	239,077	0.92*
	65–74	127,446	0.90*	39,174	0.89*	23,052	0.97*	5,869	0.98	25,402	0.98	220,943	0.91*
	≥75	90,989	0.90*	22,234	0.90*	19,583	0.94*	4,196	0.97	19,142	0.92*	156,144	0.91*
Primary Site	Colorectal	28,740	0.89*	22,307	0.92*	1,427	1.15*	1,809	1.10*	414	0.86*	54,697	0.91*
	Female breast	120,974	0.88*	31,024	0.89*	5,063	0.96	8,228	1.01	6,484	0.82*	171,773	0.88*
	Lung	38,321	0.87*	9,425	0.80*	23,838	0.95*	2,996	1.26*	634	0.72*	75,214	0.89*
	Melanoma	41,327	0.85*	807	0.99	885	0.94	193	1.36*	286	2.38*	43,498	0.86*
	Prostate	40,044	0.90*	10,536	0.87*	359	0.95	191	4.44*	242	0.72*	51,372	0.90*
	All othersa	146,981	0.96*	62,763	0.90*	46,292	0.96*	7,824	1.02	78,673	0.98*	342,533	0.95*

^aAll other cancer sites reportable to cancer registries

^bOther report type includes blood/bone marrow/flow cytometry, autopsy, and none of the above